If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Alcoholism: Clinical and Experimental ResearchVolume 20 Issue 7, Pages 1202 - 1205 Published Online: 11 Apr 2006 © 2010 Research Society on Alcoholism
Abstract | References | Full Text: PDF (Size: 473K) | Related Articles | Citation Tracking Carbohydrate-Deficient Transferrin and Gamma-Glutamyl Transferase Levels during Disulfiram Therapy This research was supported in part by grants from the Karolinska Institute. Copyright 1996 The Research Society on Alcoholism KEYWORDS CDT • GGT • Biochemical Markers • Disulfiram • Antabuse ABSTRACTSerum samples for quantification of carbohydrate-deficient transferrin (CDT) and γ-glutamyl transferase (GGT) were collected from alcohol-dependent men and women upon admission to the hospital for detoxification, and repeatedly over a 3- to 5-week period of supervised disulfiram administration as outpatients. On admission, 10 of 12 patients showed CDT concentrations above the conventional cutoff limits, whereas 6 had elevated GGT values. Normalization usually occurred within 1 to 3 weeks of disulfiram treatment, after which CDT and GGT leveled out at a relatively stable individual baseline level. However, in those patients with the highest values on admission, the decline continued during the entire observation period. The time for normalization of GGT was typically longer than for CDT. In four male patients who had taken disulfiram regularly (400–800 mg every second or third day) for at least 3 months before entering the study, the CDT and GGT concentrations were stable over time and all fell within normal limits. The present results indicate that disulfiram treatment does not influence the serum level of CDT. It is also suggested that consecutive CDT and GGT measurements during outpatient treatment with disulfiram after detoxification can be used to identify the individual baseline (Le., abstinence) values for CDT and GGT, and, furthermore, for monitoring treatment outcome. Received for publication March 29, 1996; accepted June 19, 1996 |